Kabra Drugs Ltd.

₹26.99

- 0.18 (-0.66%)

04:01 pm - close price

BSE: KABRADG

NSE:

Industry: Pharmaceuticals & Drugs

House: Private

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Standalone

Reported EPS

N/A

❌

Adjusted EPS

N/A

❌

Return On Capital Employed (ROCE)

N/A

❌

Current Ratio

N/A

❌

Return On Equity (ROE)

N/A

❌

Debt to Total Assets

N/A

❌

Scroll vertically to see more ratios

Reported EPS

N/A

❌

Adjusted EPS

N/A

❌

Return On Capital Employed (ROCE)

N/A

❌

Current Ratio

N/A

❌

Return On Equity (ROE)

N/A

❌

Debt to Total Assets

N/A

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	-	-	-	-	-
Liabilities+	-	-	-	-	-

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	-	-	-	-	-
Cash from Investing Activity	-	-	-	-	-
Cash from Financing Activity	-	-	-	-	-
Net Cash Flow	-	-	-	-	-
Opening Cash & Cash Equivalents	-	-	-	-	-
Closing Cash & Cash Equivalents	-	-	-	-	-

Shareholder Pattern

In %	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23
Promoters+	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Public+	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	8862	8098	7449	7435	7343	7367	7336	7364	7396	7415

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	-	-	-	-	-
Cash from Investing Activity	-	-	-	-	-
Cash from Financing Activity	-	-	-	-	-
Net Cash Flow	-	-	-	-	-
Opening Cash & Cash Equivalents	-	-	-	-	-
Closing Cash & Cash Equivalents	-	-	-	-	-

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	-	-	-	-	-
Liabilities+	-	-	-	-	-

Ratios

Standalone

Reported EPS

N/A

❌

Adjusted EPS

N/A

❌

Return On Capital Employed (ROCE)

N/A

❌

Current Ratio

N/A

❌

Return On Equity (ROE)

N/A

❌

Debt to Total Assets

N/A

❌

Scroll vertically to see more ratios

Reported EPS

N/A

❌

Adjusted EPS

N/A

❌

Return On Capital Employed (ROCE)

N/A

❌

Current Ratio

N/A

❌

Return On Equity (ROE)

N/A

❌

Debt to Total Assets

N/A

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Shareholder Pattern

In %	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23
Promoters+	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Public+	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	8862	8098	7449	7435	7343	7367	7336	7364	7396	7415

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Kabra Drugs Ltd.

₹26.99

- 0.18 (-0.66%)

04:01 pm - close price

BSE: KABRADG

NSE:

Industry: Pharmaceuticals & Drugs

House: Private

Overview